Recent Finacing
Recent Raise
ProMuc develops synthetic mucins for lubrication, antimicrobial coatings, food additives, and anti-cancer vaccine applications, combining MIT mucin biology expertise with carbohydrate chemistry from Corden Pharma.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor